DeepMed Research

The First Affiliated Hospital of Xi'an Jiaotong University

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer

Phase 3

Conditions: HER2+ Breast Cancer

Interventions: Drug: Trastuzumab
Drug: Pyrotinib
Drug: Anti-PD-1 monoclonal antibody
Drug: CDK4/6 inhibitor
Drug: Pertuzumab
Drug: Capecitabine
Drug: Nab paclitaxel
Drug: AI
Drug: T-DM1
Drug: Everolimus

First Posted Date: 2022-06-23

Last Posted Date: 2022-06-23

Lead Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Target Recruit Count: 120

Registration Number: NCT05429684

Locations: 🇨🇳
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
🇨🇳
Jin Yang, Xi'an, Shaanxi, China

Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038

Phase 2

Recruiting

Conditions: HER2-positive Breast Cancer

Interventions: Drug: Pyrotinib

First Posted Date: 2022-06-23

Last Posted Date: 2022-06-23

Lead Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Target Recruit Count: 209

Registration Number: NCT05429294

Locations: 🇨🇳
Jin Yang, Xi'an, Shaanxi, China

Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Not Applicable

Conditions: Type 2 Diabetes Mellitus With Complication

Interventions: Drug: Canagliflozin
Drug: Pioglitazone

First Posted Date: 2022-06-16

Last Posted Date: 2022-09-21

Lead Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Target Recruit Count: 80

Registration Number: NCT05422092

Perioperative Eosinophils Their Recovery in Type A Acute Aortic Dissection Prognosis

Completed

Conditions: Acute Aortic Dissection

Interventions: Other: This was a retrospective study with no intervention other than normal treatment

First Posted Date: 2022-06-08

Last Posted Date: 2022-06-08

Lead Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Target Recruit Count: 274

Registration Number: NCT05409677

Locations: 🇨🇳
First Affiliated Hospital of Xian JiaotongUniversity, Xi'an, Shaanxi, China
🇨🇳
First Affiliated Hospital of Xiann JiaotongUniversity, Xi'an, Shaanxi, China

Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy

Phase 4

Conditions: Safety
Drug Effect
Psychotropic Drugs
Anesthetics, Intravenous
Anesthetics
Recovery

Interventions: Drug: Remimazolam
Drug: Propofol group

First Posted Date: 2022-06-06

Last Posted Date: 2022-07-01

Lead Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Target Recruit Count: 300

Registration Number: NCT05406102

Locations: 🇨🇳
Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, Henan, China
🇨🇳
Qinghai University Affiliated Hospital, Xining, Qinghai, China
🇨🇳
First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

and more 6 locations

Effects of Antiviral Therapy on Patients With HBV-related HCC

Completed

Conditions: Hepatitis B Virus
Hepatocellular Carcinoma
Survival

Interventions: Other: Medication history

First Posted Date: 2022-06-06

Last Posted Date: 2022-06-21

Lead Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Target Recruit Count: 494

Registration Number: NCT05406089

Effects of Nurse-led Case Management Based on Prevention and Control of Acute Myocardial Infarction

Not Applicable

Conditions: Acute Myocardial Infarction

Interventions: Other: Routine inpatient care and post-discharge follow-up management
Other: Nurse -led case management

First Posted Date: 2022-05-20

Last Posted Date: 2022-05-20

Lead Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Target Recruit Count: 148

Registration Number: NCT05384028

Locations: 🇨🇳
Jingwen Hu, Xi'an, Shaanxi, China

Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients

Conditions: Sepsis Syndrome
Hemorrhage
MODS
AKI
Trauma
Thrombus

First Posted Date: 2022-05-19

Last Posted Date: 2022-05-19

Lead Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Target Recruit Count: 188

Registration Number: NCT05382078

Locations: 🇨🇳
First Affiliated Hospital of Xian JiaotongUniversity, Xi'an, Shaanxi, China

Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory

Recruiting

Conditions: Virus Diseases
Hepatitis B, Chronic

Interventions: Other: original therapy
Other: rescue therapy

First Posted Date: 2022-05-17

Last Posted Date: 2023-02-03

Lead Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Target Recruit Count: 110

Registration Number: NCT05376124

Locations: 🇨🇳
Shaanxi Provincial People's Hospital, Xi'an, China
🇨🇳
Ankang Central Hospital, Ankang, China
🇨🇳
Hanzhong 3201 Hospital, Hanzhong, China

and more 10 locations

Smoke of Endoscopic Gastrointestinal Surgery

Not Applicable

Conditions: Smoke
Particulate Matter
Endoscopic Surgery

Interventions: Device: Air sterilizer

First Posted Date: 2022-05-10

Last Posted Date: 2022-08-05

Lead Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Target Recruit Count: 70

Registration Number: NCT05367219

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy